Logo image of EXOD

EXODUS MOVEMENT INC - A (EXOD) Stock Fundamental Analysis

NYSEARCA:EXOD - NYSE Arca - US30209R1068 - Common Stock - Currency: USD

30.84  +1.76 (+6.05%)

After market: 30.84 0 (0%)

Fundamental Rating

6

Overall EXOD gets a fundamental rating of 6 out of 10. We evaluated EXOD against 281 industry peers in the Software industry. EXOD has an excellent financial health rating, but there are some minor concerns on its profitability. EXOD is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

EXOD had positive earnings in the past year.
EXOD had a negative operating cash flow in the past year.
In multiple years EXOD reported negative net income over the last 5 years.
In multiple years EXOD reported negative operating cash flow during the last 5 years.
EXOD Yearly Net Income VS EBIT VS OCF VS FCFEXOD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2024 0 20M -20M 40M 60M 80M 100M

1.2 Ratios

With an excellent Return On Assets value of 17.21%, EXOD belongs to the best of the industry, outperforming 92.88% of the companies in the same industry.
The Return On Equity of EXOD (18.75%) is better than 86.12% of its industry peers.
The Return On Invested Capital of EXOD (9.17%) is better than 85.41% of its industry peers.
Industry RankSector Rank
ROA 17.21%
ROE 18.75%
ROIC 9.17%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EXOD Yearly ROA, ROE, ROICEXOD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2024 0 20 -20 40

1.3 Margins

With an excellent Profit Margin value of 36.77%, EXOD belongs to the best of the industry, outperforming 97.15% of the companies in the same industry.
The Operating Margin of EXOD (22.09%) is better than 90.39% of its industry peers.
In the last couple of years the Operating Margin of EXOD has declined.
With a Gross Margin value of 70.74%, EXOD perfoms like the industry average, outperforming 55.52% of the companies in the same industry.
EXOD's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 22.09%
PM (TTM) 36.77%
GM 70.74%
OM growth 3Y-20.86%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.53%
GM growth 5Y42.83%
EXOD Yearly Profit, Operating, Gross MarginsEXOD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2024 0 50

More info and screens

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), EXOD is destroying value.
Compared to 5 years ago, EXOD has more shares outstanding
There is no outstanding debt for EXOD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
EXOD Yearly Shares OutstandingEXOD Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2024 5M 10M 15M 20M 25M
EXOD Yearly Total Debt VS Total AssetsEXOD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2024 50M 100M 150M 200M 250M

2.2 Solvency

EXOD has an Altman-Z score of 25.05. This indicates that EXOD is financially healthy and has little risk of bankruptcy at the moment.
EXOD's Altman-Z score of 25.05 is amongst the best of the industry. EXOD outperforms 94.66% of its industry peers.
There is no outstanding debt for EXOD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 25.05
ROIC/WACC0.8
WACC11.43%
EXOD Yearly LT Debt VS Equity VS FCFEXOD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2024 0 50M 100M 150M 200M 250M

2.3 Liquidity

A Current Ratio of 11.48 indicates that EXOD has no problem at all paying its short term obligations.
The Current ratio of EXOD (11.48) is better than 95.02% of its industry peers.
A Quick Ratio of 11.48 indicates that EXOD has no problem at all paying its short term obligations.
EXOD has a Quick ratio of 11.48. This is amongst the best in the industry. EXOD outperforms 95.02% of its industry peers.
Industry RankSector Rank
Current Ratio 11.48
Quick Ratio 11.48
EXOD Yearly Current Assets VS Current LiabilitesEXOD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2024 20M 40M 60M 80M

More info and screens

5

3. Growth

3.1 Past

EXOD shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 71.14% yearly.
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-125.8%
Revenue 1Y (TTM)N/A
Revenue growth 3Y6.65%
Revenue growth 5Y71.14%
Sales Q2Q%23.87%

3.2 Future

EXOD is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -10.15% yearly.
Based on estimates for the next years, EXOD will show a very strong growth in Revenue. The Revenue will grow by 37.45% on average per year.
EPS Next Y-47.01%
EPS Next 2Y-10.15%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year47.88%
Revenue Next 2Y37.45%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
EXOD Yearly Revenue VS EstimatesEXOD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
EXOD Yearly EPS VS EstimatesEXOD Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 0.5 1 1.5 2

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 23.91, EXOD is valued on the expensive side.
EXOD's Price/Earnings ratio is a bit cheaper when compared to the industry. EXOD is cheaper than 76.51% of the companies in the same industry.
EXOD is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.25, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 15.97, the valuation of EXOD can be described as correct.
85.41% of the companies in the same industry are more expensive than EXOD, based on the Price/Forward Earnings ratio.
EXOD is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.80, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 23.91
Fwd PE 15.97
EXOD Price Earnings VS Forward Price EarningsEXOD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, EXOD is valued a bit cheaper than 78.65% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 23.97
EXOD Per share dataEXOD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

EXOD has a very decent profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as EXOD's earnings are expected to decrease with -10.15% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-10.15%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

EXOD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EXODUS MOVEMENT INC - A

NYSEARCA:EXOD (7/31/2025, 8:21:27 PM)

After market: 30.84 0 (0%)

30.84

+1.76 (+6.05%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-12 2025-05-12/amc
Earnings (Next)08-06 2025-08-06
Inst Owners8.04%
Inst Owner Change4.98%
Ins Owners31.84%
Ins Owner Change4.49%
Market Cap890.35M
Analysts86.67
Price Target60.27 (95.43%)
Short Float %12.53%
Short Ratio2.61
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-9.04%
Min EPS beat(2)-65.46%
Max EPS beat(2)47.39%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)18.67%
Min Revenue beat(2)-5.68%
Max Revenue beat(2)43.03%
Revenue beat(4)1
Avg Revenue beat(4)0.18%
Min Revenue beat(4)-18.8%
Max Revenue beat(4)43.03%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.74%
PT rev (3m)12.97%
EPS NQ rev (1m)-9.41%
EPS NQ rev (3m)-4.3%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-13.66%
Revenue NQ rev (3m)-4.91%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 23.91
Fwd PE 15.97
P/S 7.23
P/FCF N/A
P/OCF N/A
P/B 3.69
P/tB 15.16
EV/EBITDA 23.97
EPS(TTM)1.29
EY4.18%
EPS(NY)1.93
Fwd EY6.26%
FCF(TTM)-0.66
FCFYN/A
OCF(TTM)-0.65
OCFYN/A
SpS4.27
BVpS8.37
TBVpS2.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 17.21%
ROE 18.75%
ROCE 10.62%
ROIC 9.17%
ROICexc 12.14%
ROICexgc 219.94%
OM 22.09%
PM (TTM) 36.77%
GM 70.74%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-4.25%
ROICexcg growth 5YN/A
ROICexc growth 3Y-46.6%
ROICexc growth 5YN/A
OM growth 3Y-20.86%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.53%
GM growth 5Y42.83%
F-ScoreN/A
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 7.3%
Cap/Sales 0.3%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 11.48
Quick Ratio 11.48
Altman-Z 25.05
F-ScoreN/A
WACC11.43%
ROIC/WACC0.8
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-125.8%
EPS Next Y-47.01%
EPS Next 2Y-10.15%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3Y6.65%
Revenue growth 5Y71.14%
Sales Q2Q%23.87%
Revenue Next Year47.88%
Revenue Next 2Y37.45%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3Y-15.6%
EBIT growth 5YN/A
EBIT Next Year10.2%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A